Frontlight ResearchEarly access
Active, not recruitingNo phase
Myopia Control With a Innovative Spectacle Lens - A Cessation Study
Key facts
- Who runs it
- Essilor International
- Where
- Boston, Chicago, New York, Pittsburg, and Vestal, United StatesSee the 5 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 91 people enrolled
- Started
- 18 Feb 2025
- Expected to end
- Nov 2026
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Single Vision Lens to A innovative spectacle lens
- Record updated
- 11 September 2026
Who can take part
- Age
- 9 years to 15 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (4)Hide the full registry criteria
Who can take part
- Existing subjects from the NCT05174780 clinical study
- Ability to comply with study procedures
- Informed consent of parent/guardian and assent of subject
Who cannot take part
- Current ocular infection, inflammation, or irritation likely to affect vision
Where in United States
- New England College of OptometryBoston, United States
- Illinois College of OptometryChicago, United States
- SUNY College of OptometryNew York, United States
- Kannarr Eye CarePittsburg, United States
- Sacco Eye GroupVestal, United States
About the trial
What the trial wants to find out
The purpose of this study is to quantify myopic progression following cessation of a innovative spectacle lenses after 3 years' use.
The 2 groups in the trial
- (Previous Test Group) - Single Vision Spectacle Lens - Innovative LensTreatment being tested
Treatment: Single Vision Lens to A innovative spectacle lens
- (Previous Control Group) - Single Vision Spectacle Lens - Innovative LensPlacebo, for comparison
Treatment: Single Vision Lens to A innovative spectacle lens
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Clinical Evaluation of A Innovative Spectacle Lens in Slowing Myopia Progression - A Cessation Study
- Record updated
- 11 September 2026